Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

$4,450 $4,650

**GROSS MARGIN approx. 77%

**SG&A approx. 27%

**R&D approx. 17%

Net Interest / Other approx. 60

TAX RATE - GAAP approx. 30%

*TAX RATE - NON-GAAP approx. 31%

GENZ GAAP EPS approx. $2.65

AMORTIZATION approx. $0.55

FAS123 EXPENSE approx. $0.60

CONTINGENT CONVERTIBLE DEBT approx. $0.10

**GENZ NON-GAAP EPS $3.90

***WTD AVERAGE SHARES O/S approx. 274

CAPITAL EXPENDITURES approx. $500

This financial guidance, which is provided as part of a press release

dated April 21, 2008, is subject to all of the qualifications and

limitations described therein. Actual results may differ from these

forward-looking statements due to the numerous factors described in the

press release.

* Non-GAAP tax rate excludes the impact of amortization, one-time events,

FAS123R expense and EITF 04-8.

**Non-GAAP excludes the impact of amortization, one-time events, FAS123R

expense and EITF 04-8.

***WTD Average Shares Outstanding excludes the impact of EITF 04-8.


'/>"/>
SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Vala Sciences was recently awarded ... Agency (EPA). This new contract was awarded for ... tests designed to assess the effect of chemical ... connections between neurons (synapses), which are critical for ... by environmental pollutants likely contributes to a variety ...
(Date:7/29/2014)... July 30, 2014 SoundConnect ... collaboration company, is proud to announce the strategic ... positions in their Boston, Charleston and Atlanta offices. ... the increased demand for hosted solutions, collaboration and ... and reduce cost. , SoundConnect was founded in ...
(Date:7/29/2014)... , July 29, 2014   Sequenom, Inc. ... company that provides innovative genetic analysis solutions, and ... esoteric laboratory services in the United States ... prenatal testing patents and applications. "We have ... and patient care, and we welcome the opportunity to ...
(Date:7/29/2014)... a new way of manufacturing microstructured surfaces that ... self-assembly of carbon nanotubes, could exhibit a variety ... and strength, or the ability to repel water ... that mechanical forces can be used to direct ... we can independently control the mechanical properties ...
Breaking Biology Technology:U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3SoundConnect Organization and Culture is Evolving 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4A new way to make microstructured surfaces 2
... Processes and products based on,biomass and industrial ... in a wide range of applications such as,bioplastics. ... industrial,biotechnology in Germany will be held at the ... 2008) in Chicago, Illinois.,The panel runs from 10:45am ...
... be Produced in Changzhou Hi-Tech ... District, ... inactivated rabies animal vaccines was recently launched in,Changzhou National High-tech District, ... team of leading overseas scientists. It is,reported that it is the ...
... 25 Arpida Ltd.,(SWX: ARPN) today announced that Dr ... Officer. Dr Jurgen Raths commands extensive,knowledge in the commercialisation ... and has successfully built and lead the European,Critical Care ... for many years., At the Annual General Meeting ...
Cached Biology Technology:World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment 2Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 2Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 3Leadership Change to Enable Arpida to Become a Fully Integrated Pharmaceutical Company 2Leadership Change to Enable Arpida to Become a Fully Integrated Pharmaceutical Company 3Leadership Change to Enable Arpida to Become a Fully Integrated Pharmaceutical Company 4
(Date:7/30/2014)... Progress in developing robust therapies for spinal cord injury ... has been slow. A great deal has been learned ... factors and the environmental factors that regulate axon growth, ... resulted in clinically available therapeutics. Prof. Lemmon and his ... therapeutic bottleneck has many root causes, but a consensus ...
(Date:7/30/2014)... online today in the journal Scientific Reports , ... and Auroop Ganguly found that while global temperature is ... extremes. For instance, while each year,s average hottest and ... tend to fall within a wider range of potential ... observed. This means that even as overall temperatures rise, ...
(Date:7/29/2014)... you,ve ever ordered the wrong food at a restaurant, don,t ... have less to do with what you want and more ... analyzing 217 menus and the selections of over 300 diners, ... Journal of Hospitality Management showed that when it comes ... what you see on the menu and how you imagine ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2Menu secrets that can make you slim by design 2
... 2010 New evidence that genetics play a significant role ... can do everything right and still give birth too soon. ... for Maternal-Fetal Medicine (SMFM) meeting -- The Pregnancy Meeting -- ... fetus can make them susceptible to an inflammatory response that ...
... Himalayan mountains are thinning is not disputed. However, few ... causes. Lawrence Berkeley National Laboratory scientist Surabi Menon set ... blamed culpritgreenhouse gases, such as carbon dioxidefrom other particles ... Menon and her collaborators found that airborne black carbon ...
... could predict which patients with the lung-scarring disease known as ... an indicator that could one day influence their treatment, according ... Their findings, published online last week in PLoS One ... tissue, suggesting that IPF is in fact an immunologic disease. ...
Cached Biology News:New research shows genes of pregnant women and their fetuses can increase the risk of preterm labor 2Black carbon a significant factor in melting of Himalayan glaciers 2Black carbon a significant factor in melting of Himalayan glaciers 3Test could predict which idiopathic pulmonary fibrosis patients will become severely ill 2
...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
...
... Signets Xylene Resistant (X/R) Red ... Chromogen, X/R Red Activator and X/R ... reacts with alkaline phosphatase to produce ... mounted. ,Kit Contains:, , Buffer, ...
Biology Products: